首页> 外国专利> METHOD FOR INTRAOCULAR LENS IMPLANTATION INTO PATIENTS SUFFERING FROM ECTOPIA LENTIS

METHOD FOR INTRAOCULAR LENS IMPLANTATION INTO PATIENTS SUFFERING FROM ECTOPIA LENTIS

机译:眼睑异位症患者眼内镜植入方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used in an intraocular lens (IOL) implantation into the patients suffering from ectopia lentis. That is ensured by making a corneal tunnel incision with a keratome at 9-12 o'clock. An anterior capsule of the lens is stained through this incision, and a viscoelastic is introduced. A paracentesis is made in a point remote as much as possible from the visible portion of an equator of the lens within the range of 3 to 9 o'clock. A circular capsulorhexis is performed in the anterior capsule of the lens. Hydrodissection is performed. An intracapsular ring (ICR) is implanted. A retention needle suture is pre-fixed therein. Another hydrodissection is performed again. Phacoemulsification of the lens is performed. A guide needle is used to puncture the sclera at 2.0-3.0 mm from the limb behind the paracentesis. That is followed by removing the guide needle with the suture with its free end delivered from the opposite side through the corneal tunnel incision. The IOL is implanted. The suture is thrown over from the ICR through one of the haptic elements of the IOL. The needle is delivered through the scleral opening inside the sclera towards the cornea so that the needle is brought out at 1-3 mm in front of the limb. A support element is formed with the intracapsular ring + capsular sac + IOL structure attached behind it. The needle is delivered through the same puncture in the same direction at an angle from the previous corneal pass. It is brought out from the paracentesis. The IOL is aligned with respective suture tightening. The suture is knotted and immersed into the corneal stroma in the paracentesis. The viscoelastic is removed from the anterior chamber, the capsular sac and from under the lens. The corneal stromas are sealed by graduated hydration. A glucocorticoid preparation and an antibiotic solution are administered subconjunctivally.;EFFECT: method enables relieving Marfan's symptom with a minimum effect on the vitreous body and eliminates a necessity of the following surgical management.;3 ex
机译:技术领域本发明涉及医学,即眼科,并且可以用于将眼内晶状体(IOL)植入到患有轻度外翻的患者中。在9点至12点钟用角膜刀切开角膜隧道切口即可确保这一点。通过该切口将晶状体的前囊染色,并引入粘弹性。在3到9点钟范围内,在离镜片的赤道可见部分尽可能远的位置进行穿刺穿刺。在晶状体的前囊中进行圆形撕囊。进行水解剖。植入囊内环(ICR)。固定针缝线预先固定在其中。再次进行另一次水解剖。进行晶状体的超声乳化。穿刺穿刺引导针用于在距肢体2.0-3.0毫米处刺穿巩膜。随后,将带有缝线的引导针移开,其自由端从相反侧通过角膜隧道切口递送。人工晶体被植入。缝合线是通过IOL的触觉元件之一从ICR抛出的。针头通过巩膜内侧的巩膜开口向角膜输送,以使针头在肢体前方1-3毫米处引出。支撑元件形成为在其后附有囊内环+囊囊+ IOL结构。与先前的角膜通道成一定角度,以相同的方向沿相同的方向刺入针头。它是从穿刺放出的。 IOL与各自的缝合线拧紧对齐。将缝合线打结并浸入穿刺穿刺术中的角膜基质中。从前房,囊囊和晶状体下方去除粘弹性。角膜基质通过逐渐水化被密封。结膜下给予糖皮质激素制剂和抗生素溶液。效果:该方法能够缓解Marfan症状,对玻璃体的影响最小,并且无需进行以下外科手术。3

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号